Last reviewed · How we verify
NCT02426853
Ultraviolet (UV) Photography in Adolescents
EARLY_PHASE1 trial testing Questionnaires in Cancer Prevention in 293 participants. Completed in 14 September 2020.
14 September 2020
Quick facts
| Lead sponsor | M.D. Anderson Cancer Center |
|---|---|
| Phase | EARLY_PHASE1 |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 293 |
| Start date | 21 April 2015 |
| Primary completion | 14 September 2020 |
| Estimated completion | 14 September 2020 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Questionnaires
- Photos
- Pamphlets
Conditions studied
- Cancer Prevention — all drugs for Cancer Prevention →
Sponsor
M.D. Anderson Cancer Center — full company profile →
Who can join
Adults 12 to 14, any sex, with Cancer Prevention. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this research study is to learn how students react to seeing a photograph of any skin damage they may have on their face. This skin damage may be caused by sun exposure or use of tanning beds. Researchers also want to learn about students' sun protection, tanning behaviors, and attitudes towards sun exposure, sun protection, tanning behaviors and skin cancer. Researchers will use the results of this study to design programs for students about sun protection and tanning avoidance.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT02426853
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Questionnaires
Trials testing the same drug.
- NCT07255495 — Effects of Neuromuscular Scoliosis Surgery on Nutritional Metabolism · NA · not yet recruiting
- NCT07499518 — Fertility and Polycystic Ovary Syndrome · not yet recruiting
- NCT07487844 — Pulsed Electric Field Ablation for Metastatic Breast Cancer · NA · not yet recruiting
- NCT07344649 — Turkish Validation of the Nijmegen Questionnaire in COPD · recruiting
- NCT06836414 — Lung Cancer Screening CT for Firefighters · NA · withdrawn
Other recruiting trials for Cancer Prevention
Currently open trials in the same condition.
- NCT07219706 — Dietary Fiber and Time Restricted Eating · NA · recruiting
- NCT07225881 — Eatwell Clinical Trial (R01) · NA · recruiting
- NCT07501689 — Using Middle School Science Teachers to Address Cancer Health Disparities · NA · recruiting
- NCT07086833 — The Food Environment, Microbial Cysteine Metabolism, and Cancer Disparities · NA · recruiting
- NCT06421324 — Personalised Health Recommendations to the General Population Through an Integrated AI Guided · NA · recruiting
Other M.D. Anderson Cancer Center trials
Trials by the same sponsor.
- NCT07053020 — A Phase 1b/2 Open-label, Dose-ranging Safety and Efficacy Study of Oral Cladribine in Patients With Acute Myeloid Leukem · Phase 1, PHASE2 · not yet recruiting
- NCT07052994 — A Phase Ia/Ib Trial of Revumenib Combined With Cytarabine, Daunorubicin, and Gemtuzumab Ozogamicin (GO) in Frontline and · Phase 1 · not yet recruiting
- NCT07137481 — Phase II Study of CD5 CAR Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Che · Phase 2 · not yet recruiting
- NCT07162480 — Phase II Trial of Puxitatug Samrotecan (AZD8205) in Advanced, Recurrent or Metastatic (R/M) Aggressive Adenoid Cystic Ca · Phase 2 · not yet recruiting
- NCT07076498 — Engineered HSV-1 M032 for the Treatment of Children and Adults With Newly Diagnosed Diffuse Midline Glioma After Standar · Phase 1 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT02426853 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by M.D. Anderson Cancer Center
- Last refreshed: 14 October 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02426853.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing